On the fly News and insights, exclusive to thefly.com

EPM

Evolution Petroleum

$6.53 /

+0.38 (+6.18%)

, EYPT

EyePoint

$1.63 /

+0.06 (+3.82%)

19:03
09/11/19
09/11
19:03
09/11/19
19:03

Fly Intel: After Hours Movers

UP AFTER EARNINGS: Evolution Petroleum (EPM) up 4.0%. ALSO HIGHER: Eyepoint Pharma (EYPT) up 2.5% after being initiated with Buy at Guggenheim... Yelp (YELP) up 2.5% after WSJ speculation about potential acquisition interest from Groupon (GRPN), which is down 4.0%. DOWN AFTER EARNINGS: Tailored Brands (TLRD) down 25.3%... Aurora Cannabis (ACB) down 10.5%... Oxford Industries (OXM) down 9.2%... Oracle (ORCL) down 1.9%. ALSO LOWER: Celsius Holdings (CELH) down 17.3% after equity offering... Catalyst Pharma (CPRX) down 9.8% after equity offering... DXC Technology (DXC) down 6.8% after announcing resignation of CEO... Landstar (LSTR) down 5.2% after negative Q3 pre-announcement, saying it will not meet low end of Q3 earnings guidance... Apellis Pharma (APLS) down 4.3% after convertible debt offering... Fate Therapeutics (FATE) down 3.7% after equity offering... Amneal Pharma (AMRX) down 1.7% after being initiated with Sell at Guggenheim. Movers as of 18:30ET.

EPM

Evolution Petroleum

$6.53 /

+0.38 (+6.18%)

EYPT

EyePoint

$1.63 /

+0.06 (+3.82%)

YELP

Yelp

$35.55 /

+1.55 (+4.56%)

GRPN

Groupon

$2.89 /

-0.09 (-3.02%)

TLRD

Tailored Brands

$5.33 /

-1.34 (-20.09%)

ACB

Aurora Cannabis

$5.84 /

-0.53 (-8.32%)

OXM

Oxford Industries

$72.59 /

-5.93 (-7.55%)

ORCL

Oracle

$55.81 /

+0.34 (+0.61%)

CELH

Celsius Holdings

$4.20 /

+0.32 (+8.25%)

CPRX

Catalyst Pharmaceuticals

$6.65 /

-0.39 (-5.54%)

DXC

DXC Technology

$34.00 /

-2.11 (-5.84%)

LSTR

Landstar System

$117.62 /

+1.94 (+1.68%)

APLS

Apellis

$30.21 /

-0.87 (-2.80%)

FATE

Fate Therapeutics

$17.71 /

-1.38 (-7.23%)

AMRX

Amneal Pharmaceuticals

$3.43 /

-0.16 (-4.46%)

  • 11

    Sep

  • 11

    Sep

  • 11

    Sep

  • 11

    Sep

  • 12

    Sep

  • 12

    Sep

  • 19

    Sep

  • 19

    Sep

  • 23

    Sep

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 24

    Oct

  • 06

    Nov

  • 13

    Nov

  • 12

    Sep

  • 13

    Sep

EPM Evolution Petroleum
$6.53 /

+0.38 (+6.18%)

02/11/19 Roth Capital
Evolution Petroleum upgraded to Buy from Neutral at Roth Capital
09/17/18
Evolution Petroleum upgraded to Buy from Neutral at Euro Pacific
EYPT EyePoint
$1.63 /

+0.06 (+3.82%)

09/11/19 Guggenheim
EyePoint initiated with a Buy at Guggenheim
09/11/19 Guggenheim
EyePoint initiated with a Buy at Guggenheim
11/13/18 H.C. Wainwright
Ocular Therapeutix now highly likely to receive J-code, says H.C. Wainwright
10/01/18 H.C. Wainwright
EyePoint price target raised to $4.50 from $2.75 at H.C. Wainwright
YELP Yelp
$35.55 /

+1.55 (+4.56%)

08/09/19 DA Davidson
Yelp CFO departure another indication of possible sale, says DA Davidson
06/04/19 Aegis
Yelp upgraded to Hold from Sell at Aegis
05/10/19 B. Riley FBR
Yelp downgraded to Neutral on declining pricing visibility at B Riley FBR
05/10/19 B. Riley FBR
Yelp downgraded to Neutral from Buy at B. Riley FBR
GRPN Groupon
$2.89 /

-0.09 (-3.02%)

02/04/19
Fly Intel: Top five analyst initiations
02/04/19 Goldman Sachs
Groupon initiated with a Neutral at Goldman Sachs
09/14/18 DA Davidson
Groupon is 'attractively priced', says DA Davidson
09/14/18 Wedbush
Groupon initiated with a Neutral at Wedbush
TLRD Tailored Brands
$5.33 /

-1.34 (-20.09%)

06/13/19 B. Riley FBR
Tailored Brands price target lowered to $7 from $10 at B. Riley FBR
03/14/19 Jefferies
Jefferies cuts Tailored Brands target to $19, admits to making 'terrible' call
03/14/19 B. Riley FBR
Tailored Brands downgraded to Neutral from Buy at B. Riley FBR
12/18/18
Fly Intel: Top five analyst initiations
ACB Aurora Cannabis
$5.84 /

-0.53 (-8.32%)

08/13/19 Piper Sandler
Aurora Cannabis initiated with a Neutral at Piper Jaffray
08/12/19 Piper Sandler
Aurora Cannabis initiated with a Neutral at Piper Jaffray
07/18/19 BofA
Aurora Cannabis downgraded to Neutral from Buy at BofA/Merrill
07/17/19 Ladenburg
Aurora Cannabis initiated with a Buy at Ladenburg
OXM Oxford Industries
$72.59 /

-5.93 (-7.55%)

04/16/19 Citi
Oxford Industries assumed with a Buy at Citi
12/28/18 CL King
Oxford Industries initiated with a Buy at CL King
12/13/18 KeyBanc
Oxford Industries price target lowered to $90 from $104 at KeyBanc
12/13/18 DA Davidson
Oxford Industries downgraded to Neutral from Buy at DA Davidson
ORCL Oracle
$55.81 /

+0.34 (+0.61%)

08/16/19 Cowen
Oracle on more stable footing with execution of growth initiatives, says Cowen
08/06/19
Oracle management to meet with UBS
07/19/19 Stifel
Microsoft price target raised to $155 from $150 at Stifel
06/26/19 Wedbush
Pentagon JEDI contract to be 'defining moment' for cloud arms race, says Wedbush
CELH Celsius Holdings
$4.20 /

+0.32 (+8.25%)

CPRX Catalyst Pharmaceuticals
$6.65 /

-0.39 (-5.54%)

08/08/19 Cantor Fitzgerald
Catalyst price target raised to $12 from $10 at Cantor Fitzgerald
08/08/19 Truist
SunTrust says buy Catalyst on weakness, boosts price target to $11
08/08/19 Truist
Catalyst Pharmaceuticals price target raised to $11 from $9 at SunTrust
08/08/19 Piper Sandler
Catalyst target raised to $8 on launch execution at Piper Jaffray
DXC DXC Technology
$34.00 /

-2.11 (-5.84%)

08/09/19 Cowen
DXC Technology price target lowered to $65 from $83 at Cowen
08/09/19 KeyBanc
DXC Technology downgraded to Sector Weight from Overweight at KeyBanc
08/09/19 BMO Capital
DXC Technology downgraded to Market Perform from Outperform at BMO Capital
05/24/19 Wells Fargo
DXC Technology price target lowered to $55 from $72 at Wells Fargo
LSTR Landstar System
$117.62 /

+1.94 (+1.68%)

07/02/19
Fly Intel: Top five analyst upgrades
07/02/19 Raymond James
Landstar System upgraded to Market Perform from Underperform at Raymond James
06/28/19 Wolfe Research
Landstar System upgraded to Peer Perform from Underperform at Wolfe Research
06/06/19 Credit Suisse
Landstar System price target lowered to $104 from $112 at Credit Suisse
APLS Apellis
$30.21 /

-0.87 (-2.80%)

07/12/19 JPMorgan
Apellis upgraded to Overweight with $49 price target at JPMorgan
07/12/19 JPMorgan
Apellis upgraded to Overweight from Neutral at JPMorgan
07/09/19
Oppenheimer bullish on Apellis, initiates with an Outperform
07/08/19 Oppenheimer
Apellis initiated with an Outperform at Oppenheimer
FATE Fate Therapeutics
$17.71 /

-1.38 (-7.23%)

08/09/19 BTIG
Fate Therapeutics initiated with a Buy at BTIG
08/09/19 BTIG
Fate Therapeutics initiated with a Buy at BTIG
08/07/19 Wedbush
Fate Therapeutics price target raised to $26 from $21 at Wedbush
07/22/19 Cantor Fitzgerald
Fate Therapeutics initiated with an Overweight at Cantor Fitzgerald
AMRX Amneal Pharmaceuticals
$3.43 /

-0.16 (-4.46%)

09/11/19 Guggenheim
Amneal Pharmaceuticals assumed with a Sell at Guggenheim
09/11/19 Guggenheim
Amneal Pharmaceuticals initiated with a Sell at Guggenheim
08/06/19 Truist
Amneal Pharmaceuticals price target lowered to $5 from $9 at SunTrust
07/30/19 Piper Sandler
Piper says Alkermes scores 'back-to-back wins' with settlement, Biogen data

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.